Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Shares Surge 15.3 Percent On News of Q4 MassArray Placements

NEW YORK, Jan. 5 (GenomeWeb News) - Shares in Sequenom were up 15.3 percent at $1.44 in strong volume in mid-afternoon trade after the company said it has delivered nine MassArray systems during the fourth quarter.


The San Diego-based high-throughout-genotyping company said the placements bring to 20 the total systems delivered in 2004. Sequenom added that the recently approved MassArray Compact system helped drive the placements.

Sequenom began selling the compact MassArray in September 2003. The product, which is 73 percent smaller than the full-size system, takes 45 minutes to run a single plate, according to a company spokesperson. The standard MassArray platform takes around 25 minutes.

Another difference is that the compact system holds two chips per plate, whereas the larger one holds 10. With its softer throughput and a price tag of around $285,000 without the liquid handler - the larger instrument runs around $500,000 - the spokesperson, who has since left the company, said the junior platform will be marketed to smaller academic labs and to the clinical-research market.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.